NovaBay Pharmaceuticals Introduces Hydrating Cleansing Oil to its DERMAdoctor Calm Cool + Corrected Product Line
April 01 2022 - 6:50AM
Business Wire
Soap-free and pH-balanced formula features
jojoba seed and orange peel oils to gently lift away impurities and
remove makeup without drying skin
NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a
pharmaceutical company developing and commercializing high-quality,
scientifically formulated eyecare and skincare products, announces
the launch of Hydrating Cleansing Oil as the newest product under
the DERMAdoctor Calm Cool + Corrected brand. Hydrating Cleansing
Oil is a soap-free, pH-balanced cleanser that moisturizes and
removes makeup while keeping skin hydrated. It was created by
Audrey Kunin, MD, NovaBay’s Chief Product Officer and a
board-certified dermatologist, to deeply cleanse dry, sensitive or
eczema-prone skin.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20220401005060/en/
DERMAdoctor Calm Cool + Corrected
Hydrating Cleansing Oil (Photo: Business Wire)
Calm Cool + Corrected Hydrating Cleansing Oil is available in a
200 ml size for $30.00 at Amazon.com and dermadoctor.com, which
also offers monthly auto-delivery at a 15% discount along with free
shipping. The cleansing oil is applied to dry skin, followed by a
splash of warm water and rubbing with fingertips in a gentle
circular motion to transform the oil into a milky consistency prior
to rinsing.
“The simple act of washing your face can lead to dehydration,
and this new rich, moisture-replenishing, deep-cleansing oil
hydrates sensitive facial skin without clogging pores. Our new luxe
cleansing oil lifts away impurities and removes makeup while gently
exfoliating skin, leaving complexions feeling soft, refreshed and
luminous,” said Dr. Kunin. “We are delighted to expand the range of
innovative products under the DERMAdoctor umbrella, and look
forward to additional launches throughout the coming year.”
Hydrating Cleansing Oil is a proprietary formulation of jojoba
seed oil to calm and soothe skin, orange peel oil to add antiseptic
and anti-aging benefits, hibiscus extract, which is rich in
antioxidants with natural alpha-hydroxy acids to fight free radical
damage, and mother of pearl extract to help brighten skin. It is
infused with electrolytes, minerals and antioxidants to optimize
skin health.
Hydrating Cleansing Oil joins the recently launched Moisture
Recover HA Serum as the newest additions to DERMAdoctor’s Calm Cool
+ Corrected collection, which is designed to help soothe and
comfort skin that’s prone to irritation including eczema and
rosacea. Like all Calm Cool + Corrected products, Hydrating
Cleansing Oil is clean, allergy-tested and hypoallergenic, free of
synthetic dyes and cruelty-free with no animal testing.
About NovaBay Pharmaceuticals, Inc:
NovaBay Pharmaceuticals, Inc. is a pharmaceutical company that
develops and sells scientifically created and clinically proven
consumer products for the eyecare and skincare markets. Avenova® is
the most prescribed antimicrobial lid and lash spray and
DERMAdoctor is a premium skincare brand offering more than 30
dermatologist-developed skincare products sold through traditional
domestic retailers, digital beauty channels and international
distributors.
NovaBay Pharmaceuticals Forward-Looking Statements
Except for historical information herein, matters set forth in
this press release may be forward looking within the meaning of the
“safe harbor” provisions of the Private Securities Litigation
Reform Act of 1995, including statements about the commercial
progress and future financial performance of NovaBay
Pharmaceuticals, Inc. This release contains forward-looking
statements that are based upon management’s current expectations,
assumptions, estimates, projections and beliefs. These statements
include, but are not limited to, statements regarding our business
strategies, current product offerings, marketing efforts, and any
future revenue that may result from selling such products, as well
as generally the Company’s expected future financial results. These
statements involve known and unknown risks, uncertainties and other
factors that may cause actual results or achievements to be
materially different and adverse from those expressed in or implied
by the forward-looking statements. Factors that might cause or
contribute to such differences include, but are not limited to,
risks and uncertainties relating to the size of the potential
market for our products, the integration of DERMAdoctor’s business
into the Company’s business, the possibility that the available
market for the Company’s products will not be as large as expected,
the Company’s products will not be able to penetrate one or more
targeted markets, and revenues will not be sufficient to meet the
Company’s cash needs. Other risks relating to NovaBay’s business,
including risks that could cause results to differ materially from
those projected in the forward-looking statements in this press
release, are detailed in NovaBay’s latest Form 10-Q/K filings and
Registration Statement on Form S-1 filing with the Securities and
Exchange Commission, especially under the heading “Risk Factors.”
The forward-looking statements in this release speak only as of
this date, and NovaBay disclaims any intent or obligation to revise
or update publicly any forward-looking statement except as required
by law.
Socialize and Stay Informed on
NovaBay’s Progress
Like us on Facebook Follow us on Twitter Connect with NovaBay on
LinkedIn Visit NovaBay’s Website
Avenova Purchasing
Information For NovaBay Avenova purchasing information:
Please call 800-890-0329 or email sales@avenova.com Avenova.com
DERMAdoctor Purchasing
Information For DERMAdoctor purchasing information:
Please call 877-337-6237 or email service@dermadoctor.com
DERMAdoctor.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220401005060/en/
NovaBay Contact Justin Hall
Chief Executive Officer and General Counsel 510-899-8800
jhall@novabay.com
Investor Contact LHA
Investor Relations Jody Cain 310-691-7100 jcain@lhai.com
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Aug 2024 to Sep 2024
NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Sep 2023 to Sep 2024